Pages

Tuesday, November 15, 2011

PositiveID Corporation Announces Third Quarter 2011 Highlights

Third Quarter Highlights Include the Submission of the Company's iglucose 510(k) to the FDA and Completion of Phase II of its GlucoChip Glucose-Sensing Microchip DELRAY BEACH, Fla., Nov. 15, 2011 (GLOBE NEWSWIRE) -- PositiveID Corporation ("PositiveID" or "Company") (OTCBB:PSID), a developer of medical technologies for diabetes management, clinical diagnostics and bio-threat detection, announced today its third quarter 2011 operational highlights, including FDA submission of its iglucose™ 510(k) ...continued
 

No comments:

Post a Comment